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Abstract
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) are the agents of two common, sexually transmitted
diseases afflicting women in the United States (http://www.cdc.gov). We designed a novel web-based application
that offers simple recommendations to help optimize medical outcomes with CT and GC prevention and control
programs. This application takes population groups, prevalence rates, parameters for available screening assays and
treatment regimens (costs, sensitivity, and specificity), as well as budget limits as inputs. Its output suggests optimal
screening and treatment strategies for selected at-risk groups, commensurate with the clinic’s budget allocation.
Development of this tool illustrates how a clinical informatics application based on rigorous mathematics might
have a significant impact on real-world clinical issues.
Introduction and background
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae
(GC) are the etiological agents of the two most commonly
reported sexually transmitted diseases (STDs) among
women in the United States. In 2011, 1,412,791 cases of
sexually transmitted CT infection were reported to the
Centers for Disease Control and Prevention (CDC) [1].
This case count corresponds to a rate of 457.6 cases per
100,000 population, an increase of 8% over 2010. A com-
mon co-infection with CT [2], GC infection was reported
a total number of 321,849 cases, corresponding to a rate
of 104.2 cases per 100,000 population [1].
To control the spread of STDs, there are some screen-
ing guidelines available to clinics. For example, the CDC
recommends annual CT screening for sexually active
adolescents and young women [3]. The U.S. Preventive
Services Task Force (USPSTF) recommends screening all
sexually active women, including those who are pregnant,
for gonorrhea, if they are at increased risk for infection
[4]. Recent data suggest that screening rates in young
women are low, with most young women not getting
screened [5,6]. The CDC estimates that the incidence of
CT is more than twice the number actually reported [7],
at least partly because of low screening rates and the
nature of CT infection, which is often asymptomatic.
Perhaps another reason is that, detection is typically rele-
gated to public clinics, which may have insufficient bud-
gets to screen all eligible women.
To improve the efficient use of limited clinical
resources, mathematical resource allocation models have
been developed to calculate an optimal solution regard-
ing the selections of patient groups, screening assays, and
treatment regimens [5-7]. The parameters used in these
models typically come from published data [8]. However,
they may be tailored to any particular demographic
environment. Our goal, thus, has been to provide a rigor-
ous mathematical framework, into which the end-user
can insert specific parameters, adjusted to reflect local
conditions and constraints.
To achieve the goal, our approach employs three steps.
First, we have designed a mathematical model as our the-
oretical foundation to address both CT and GC infec-
tions. Second, we have analyzed and interpreted the
computational results of the proposed model. Finally, we
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have implemented the mathematical model as a web-tool
in which the local clinical manager is enabled to particu-
larize strategies to local conditions and resources.
Previously [8,9], we addressed the first two steps; here we
elaborate the final stage.
Method
Mathematical formulation
The proposed model is a nonlinear cubic binary model.
We briefly introduce the model here; see our previous
publications for details [8,9]. The patient population
comprises m groups, with r available screening assays, s
available treatment regimens with funding limitation b.
We define the following three decision variables:
xi =
{








1 if treatment regimen k is selected
0 Otherwise
The objective function is to maximize the likely rate of
cured outcomes given the available screening assays and











Popi · Curijk · xiyjzk(1)
Subject to funding availability
∑
i,j,k
Popi · Costijk · xiyjzk ≤ b (2)
Where Popi represents the population of the i th group,
Curijk and Costijk represent the expected rate of cured
infection cases and the costs, correspondingly, over the
population of the ith group using the j th screening assay
and treated with k th regimen. Assuming the same




yj = 1 and
s∑
k=1
zk = 1 (3)
The solutions for the three decision variables give us an
optimal strategy, maximizing the expected number of
cured cases. This model is nonlinear, and can be con-
verted into a knapsack problem (which is a NP-hard pro-
blem) [8,9]. There is no simple, analytic solution to solve
this model [10]. Instead we adopt a reasonably efficient,
two-step branch-and-bound algorithm to give an exact
solution.
Implementation overview
Our implementation plan is to provide highly configur-
able and user-friendly, web-oriented software that allows
a clinical manager to specify parameters such as preva-
lence rate, budget availability, and costs. Accepting these
user-specified parameters, the tool aims to compute a
detailed optimal strategy commensurate with that bud-
get. Additionally the users can explore several scenarios
by adding/deleting patient groups, screening assays or
treatment regimens.
The application was developed using Java Enterprise
Edition (rendering it portable to Windows, Linux, Unix or
Mac OS), and employ Model-View-Controller (MVC)
architecture and Object-relational (OR) mapping to reduce
the amount of code, and Multi-thread programming to
speed up computation. Dynamic-HTML (DHTML) is
extensively to allow user configuration of any parameter
combination of population, screening assays and treatment
regimens easily. The application wide data is stored in
MySQL, which saves the information of user and superu-
ser. As for this information, only superusers can change
the data structure. The same database also stored the para-
meters for calculating the optimal strategy. For example,
each screening assays and regimens (e.g. the sensitivity,
specificity, unit costs and etc) based on the publish data is
saved as default reference values. It will be loaded automa-
tically as the any user initially login to the tool. The tool
also allows users to over-ride these inputs as their local site
may have individual scenario (e.g. higher/lower costs of the
assays than the default one).
Architecture and major modules
Our application adopts a multi-layer MVC architecture
shown in Figure 1a. From left to right, there are: Web
Explorer layer, Web Server layer and MySQL Database
layer. The Web Explorer layer includes the web pages
(representing View) users use to send service requests and
receive service responses. Web Server layer handles all the
business logic to process user’s requests. This layer also
contains a controller component, which accesses applica-
tion data in MySQL database (not shown in Figure 1). The
processed result is stored in model components (Java-
Beans) and routed back to the controller component,
where it constructs the result page.
The business logic can be categorized into two major
modules. The data management module analyzes various
application-wide data, such as user information, transac-
tion data, population data, and screening and treatment
data. It also identifies the user as anonymous or
advanced-users, provides help and retrieval of the default
settings. The population, screening and treatment mod-
ule is used to customize population data by adding/
removing a population group. Accordingly, this module
then automatically changes the structures of parameter
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input tables for infection and/or co-infection rates
reflected in the population data. It is also used to custo-
mize screening and/or treatment choices.
Results
To achieve the goal of calculating an optimal strategy
automatically, the mathematical model is successfully
implemented by the new web-based tool (Figure 1b and
Figure 2). This web-tool has five main pages: population
groups, infection rates, co-infection rates, screening setting
and treatment setting. If a clinical manager has difficulties,
there are also help windows available to provide tutorial
information. These pages follow each other in sequence as
a clinical manager submits his/her local parameters. For
example, the mathematical variable xi is configured within
the “population group” page, where visiting patients are
initially divided into 12 groups reflecting different
populations at local clinics (Figure 2c). The corresponding
local prevalence rate could be specified in the “infection
rate” page (Figure 2a). The “co-infection rate” page speci-
fies how likely that the CT patients in the population also
have GC. The other two variables yi and zi control the
decision on screening assays and treatment regimens, and
are specified in the “screening setting” page (Figure 3) and
“treatment setting” page (Figure 2b), correspondingly.
After the required parameters for the model are speci-
fied, this web-tool calculates the optimal strategy by sol-
ving the proposed mathematical model with the accurate,
two-step branch-and-bound algorithm. An example of a
calculated optimal solution is shown in Figure 2d. It is
interpreted as follows: after the local situation at a clinic
is specified, the optimal solution recommends screening
the black groups 20 or younger and 24 or older using BD
ProbeTec CT, and to treat those showing positive
Figure 1 (a) Multi-layer MVC architecture. (b) The welcome page. Two types of users are required.
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screening results with doxycycline. This tool also reports:
given a pre-determined budget of $50,000 (default costs
in Figure 2d), the plan suggested by the model can be
expected to cure 96 patients given the local CT and GC
prevalence rates. Furthermore, this tool also suggests that
to achieve the expected cures, $46,370 (revised costs in
Figure 2d) should be sufficient.
The other part of the goal is to allow clinical experts to
re-design the decision model. Several steps are needed to
achieve this. First, a login page was designed to classify
Figure 2 User interfaces and parameters need to be specified.
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users as “anonymous” or “advanced”. Anonymous users are
not required to have passwords to use this tool, and they
can access the basic functions of the tool needed to calcu-
late the optimal solutions as we describe above (Figure 2).
To re-design the decision model, clinical professionals have
to be authenticated as advanced-users. An advanced-user
can add or delete population groups, screening assays and
treatment regimens. The total number of underlying deci-
sion variables xi, yi and zi are updated correspondingly.
For example, Figure 3 illustrates a feature available to
advanced-users, namely the addition of a new screening
assay, including whether the assay is for CT or GC or
both (this is accomplished in a pop-up window). After
the advanced-user has added a new screening assay to
the model, the tool will re-calculate the model taking the
addition diagnostic assay into consideration, by augment-
ing the terms of decision variable yi. Analogously, add-
ing/deleting population groups and treatment regimens
will lead to a re-calculation with respect to changes in
parameters related to xi and zi(the interface webpage is
not shown). The “re-design” features give advanced-users
flexibility to re-model new situations and to tailor the
computation efficiently to his or her specific situation.
Discussion
Many efforts towards improvements of the quality of
health care have resulted in the development of clinical
decision-supports systems [11-13]. However, clinical
practitioners seem prone to rely on their own experi-
ence to solve problems instead of using decision aids
[11,14]. The barrier is due in part to the fact that prac-
tice guidelines (typically promulgated by organizations
like the CDC) do not fit local clinical situation; this is
certainly true in the case of sexually transmitted disease
control programs.
Significantly different from other clinical decision sup-
port systems [11,15,16], this new web-based tool is
designed to lower that barrier by enabling practical-
minded, clinical managers to impose their view of local
realities and still avail themselves of a rigorous mathema-
tical model for the number-crunching. This is accom-
plished without compromising ease of use, thanks to its
user friendly interfaces and didactic instructions for add-
ing or deleting new population groups, screening assays
or treatment regimens. This design not only allows users
to do “what-if” analysis, by manipulating the mathemati-
cal model with their own parameters, but also gives flex-
ibility to accomplished users to re-parameterize the
model virtually from scratch. To our knowledge, this is
the first web-based tool (which utilizes a rigorous mathe-
matical model) to offer a detailed, optimal strategy to
select at-risk patient groups, as well as screening assays
and treatment regimens for the control and prevention of
CT and GC - all within a specified budgetary constraint.
Figure 3 User may tailor his/her model by adding and deleting the screening assays.
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Of course, there are limitations to the approach and
challenges in its implementation. First, the new decision
tool depends on the underlying mathematical model,
which embodies necessary assumptions. Though para-
meters can be adjusted, the underlying assumptions are
fixed. Second, there is a theoretical computational limit
while solving the model. For example, the complexity of
the two-step branch-and-bound algorithm to the model
has an overall running time of O(n·m2m), where n is the
number of the combinations of screening and treatment
strategies satisfying conditions (3), and m is the number
of population groups [8]. As the number of division in
population groups, the choices of screening assays, and
the availability of treatment regimens increase, the com-
putational challenge increases. We are optimistic about
overcoming the computational challenge for following
reasons. The values of m and n are not huge numbers in
reality. The availability of regimens determines the value
of n. There are usually practical guidelines at each clinic,
regarding how to partite patients into m groups. Com-
mercial software applications may adopt approximation
algorithms for solving the proposed model, too. For
example, Excel Solver’s approximation algorithm some-
times calculates near-optimal solutions, while the
two-step branch-and-bound algorithm is an exact algo-
rithm which always calculates the optimal solution. We
demonstrated the advantage of using the two-step
branch-and-bound algorithm over Excel Solver’s approxi-
mation algorithm, in term of the computational accuracy
and the running time [8]. A third challenge is to provide
a reasonably quick service response – an important factor
for users expecting a timely browsing experience. To
overcome this obstacle and we have designed a dedicated
logic handler on the basis of a multi-thread programming
technique. We provide detail on threading techniques in
the Appendix. The computation time of the algorithm
thus becomes a matter of seconds [8]. Cutting edge
technology and advanced algorithm design rise to meet
the computational challenge and to satisfy user expecta-
tion of a quick response. Fourth, we are aware that the
new application needs to be tested and evaluated by
clinical managers so that it can be improved, both with
respect to its user-interfaces and its back-end algorithm.
We are currently actively seeking collaboration with
clinicians to evaluate this tool. A short follow-up report
of actual use will be ready once we have a beta testing
within a clinic and across sites evaluations could be also
reported after we receive feedback from more clinics.
Hopefully, with cooperative interaction between clini-
cian and mathematician, these limitations can be ame-
liorated, resulting in an improved tool. We are
optimistic that successful implementation of this tool
will highlight the feasibility of applying complicated
mathematical models to practical clinical problems via a
powerful informatics approach.
Appendix
The algorithm of the logical handler is sketched in
Table 1 (for master thread) and Table 2 (for slave
threads).
Note that in Table 1, after all combinations are cre-
ated, they are categorized into different types. For
example, one of the types is ct-single-screening-single-
treatment, which stands for the combination of screen-
ing and treatment plan for CT where both the screen-
ing and treatment plan are a single plan (only used for
screening/treating a single disease). After all types are
created, they are distributed into slave threads (one
type is processed by each a slave thread) to calculate
the number of cured people among the population
groups. The processing result is fed back into the mas-
ter thread. The algorithm for slave threads is described
in Table 2.
After calculating the number of people expected to be
cured, as well the associated cost of the given type of
combinations, the optimal results are obtained by sol-
ving several “knapsack” problems. For insight on how to
convert this mathematical model into knapsack pro-
blems and the details of two-step branch-and-bound
algorithm, please refer our previous publication. [8]
Table 1 The algorithm for the master thread
Procedure master (groups, screenings, treatments)
(screeningsCT, screeningsGC) = identify the list of screening plans for CT and GC, respectively.
(treatmentsCT, treatmentsGC) = identify the list of treatment plans for CT and GC, respectively.
FOR I = 1 TO screeningsCT_size
FOR J = 1 TO screeningsGC_size
FOR K = 1 TO treatmentsCT_size
FOR L = 1 TO treatmentsGC_size
Create a combination of screeningsCT[I], screeningsCT[J], treatmentsCT[K], and treatmentsGC[L].
Categorize all combinations into different types.
Distribute each type of combinations into a slave thread.
Wait for slave threads to finish the computation.
Collect all results and calculate the final optimal result.
Return the optimal result to logic handler.
End procedure master.
Zhao et al. BMC Proceedings 2013, 7(Suppl 7):S11
http://www.biomedcentral.com/1753-6561/7/S7/S11
Page 6 of 7
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
We greatly appreciate Dr. Robert M. Wohlhueter for carefully editing this
manuscript. We thank the editor and anonymous referees for their helpful
comments.
Declarations
This project is supported in part by the GSU MBD program and a GSU
mathematics assistantship.
This article has been published as part of BMC Proceedings Volume 7
Supplement 7, 2013: Proceedings of the Great Lakes Bioinformatics
Conference 2013. The full contents of the supplement are available online at
http://www.biomedcentral.com/bmcproc/supplements/7/S7.
Authors’ details
1Department of Mathematics and Statistics, Georgia State University, Atlanta,
GA 30303, USA. 2Department of Computer Science, Georgia State University,
Atlanta, GA 30303, USA.
Published: 20 December 2013
References
1. Centers for Disease Control and Prevention: Sexually Transmitted Disease
Surveillance. 2011 [http://www.cdc.gov/std/stats11/Surv2011.pdf], [cited
2013 Jul. 30].
2. Lyss SB, Kamb ML, Peterman TA, Moran JS, Newman DR, Bolan G,
Douglas JM, Iatesta M, Malotte TA, Zenilman JM, Ehret J, Gaydos C,
Newhall WJ, Project RESPECT Study Group: Chlamydia trachomatis among
patients infected with and treated for Neisseria gonorrhoeae in sexually
transmitted disease clinics in the United States. Ann Intern Med 2003,
139(3):178-85.
3. Centers for Disease Control and Prevention: Sexually Transmitted Diseases
Treatment Guidelines, 2010. MMWR Recomm Rep 2010, 59(RR-12):1-110.
4. US Preventive Services Task Force: Screening for Gonorrhea. 2005 [http://
www.uspreventiveservicestaskforce.org/uspstf/uspsgono.htm].
5. Tao G, Hoover KW, Kent C: Chlamydia testing patterns for commercially
insured women, 2008. Am J Prev Med 2012, 42(4):337-41.
6. Heijne J, Tao G, Low N, Kent C: Uptake of regular chlamydia testing by U.
S. women: a longitudinal study. Am J Prev Med 2010, 39(3):243-50.
7. Satterwhite C, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J,
Xu F, Weinstock H: Sexually transmitted infections among US women
and men: prevalence and incidence estimates, 2008. Sex Transm Dis
2013, 40(3):187-93.
8. Zhao K, Chen G, Gift T, Tao G: Optimization Model and Algorithm Help to
Screen and Treat Sexually Transmitted Diseases. International Journal of
Computational Models and Algorithms in Medicine 2010, 1(4):1-18.
9. Tao G, Zhao K, Gift T, Qiu F, Chen G: Using a Resource Allocation Model
to Better Guide Local Sexually Transmitted Diseases Control and
Prevention Programs. Operations Research for Health Care 2012, 1(2):23-9.
10. Hillier FS, Lieberman GJ: Introduction to operations research. 7 edition.
Boston :: McGraw-Hill; 2001.
11. Sintchenko V, Coiera E, Iredell JR, Gilbert GL: Comparative impact of
guidelines, clinical data, and decision support on prescribing decisions:
an interactive web experiment with simulated cases. J Am Med Inform
Assoc 2004, 11(1):71-7.
12. Jacobson SH, Sewell EC: A web-based tool for designing vaccine
formularies for childhood immunization in the United States. J Am Med
Inform Assoc 2008, 15(5):611-9.
13. Stenner SP, Chen Q, Johnson KB: Impact of generic substitution decision
support on electronic prescribing behavior. J Am Med Inform Assoc 2010,
17(6):681-8.
14. Kaplan B: Evaluating informatics applications–clinical decision support
systems literature review. Int J Med Inform 2001, 64(1):15-37.
15. Schnipper JL, Linder JA, Palchuk MB, et al: “Smart Forms” in an Electronic
Medical Record: documentation-based clinical decision support to
improve disease management. J Am Med Inform Assoc 2008, 15(4):513-23.
16. Sanders GD, Nease RF Jr, Owens DK: Design and pilot evaluation of a
system to develop computer-based site-specific practice guidelines from
decision models. Med Decis Making 2000, 20(2):145-59.
doi:10.1186/1753-6561-7-S7-S11
Cite this article as: Zhao et al.: Building a web-based tool to support
clinical decisions in the control of Chlamydia trachomatis and Neisseria
gonorrhoeae infections. BMC Proceedings 2013 7(Suppl 7):S11.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Table 2 The algorithm for slave threads
Procedure slave(groups, screenings, treatments, combinations, budget)
FOR I = 1 TO combinations_size
Get screening1, screening2 from combinations[I] and screenings;
Get treatment1, treatment2 from combinations[I] and treatments;
FOR J = 1 TO groups_size
Update combinations[I] by adding the number of cured people in groups[J] given screening1, screening2, treatment1, and
treatment2.
Update combinations[I] by adding the cost for curing people in groups[J] given screening1, screening2, treatment1, and treatment2.
Run knapsack algorithm to get the local optimal results for this type of combinations under budget.
Return the local optimal results to the master thread.
End procedure slave.
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